Market Place
Sourcing Support
CAMP4 Reports Third Quarter 2024 Financial Results
21 Nov 2024 //
GLOBENEWSWIRE
Upstream swells IPO to $255M as it lists alongside CAMP4
11 Oct 2024 //
FIERCE BIOTECH
Kaiser Permanente-backed biopharma CAMP4 raises $75 mln in US IPO
10 Oct 2024 //
REUTERS
CAMP4 Announces Pricing of Initial Public Offering
10 Oct 2024 //
GLOBENEWSWIRE
CAMP4 is latest to eye IPO, while Upstream spells out $182M plan
07 Oct 2024 //
FIERCE BIOTECH
CAMP4 Collaborates on RNA-Targeting Medicines for Rare Conditions
01 Oct 2024 //
GLOBENEWSWIRE
Kaiser Permanente-backed biopharma CAMP4 files for US IPO
21 Sep 2024 //
REUTERS
CAMP4 Secures Orphan Drug Designation for CMP-CPS-001
17 Sep 2024 //
GLOBENEWSWIRE
CAMP4 Therapeutics Gets Rare Pediatric Disease Designation For CMP-CPS-001
27 Aug 2024 //
GLOBENEWSWIRE
CAMP4 Announces Dosing of CMP-CPS-001 in P1 Study for Urea Cycle Disorders
21 Mar 2024 //
GLOBENEWSWIRE
CAMP4’s funding influx paves the way for tapping regulatory RNA
29 Jul 2022 //
PHARMACEUTICAL-TECHNOLOGY
Equipped with $100M in new cash, CAMP4 takes trail to the clinic
19 Jul 2022 //
FIERCEBIOTECH
CAMP4 Tx Appoints Veteran Drug Developer Ann Barbier, M.D., Ph.D. as CMO
14 Mar 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.